{
  "id": 5,
  "text": "IBA sold the first Cyclone KEY, launched\nto \nenable \nsmall \nand \nmedium-sized\nhospitals \nto \nproduce \ntheir \nown\nradiopharmaceutical products in-house, for\ninstallation at a hospital in Benin. IBA \nacquired \na \nUS-based \nRadcal\nCorporation, a pioneer in X-ray imaging\nquality assurance. The acquisition is\nanticipated to be revenue accretive and \nEBIT positive from 2024 onwards, and will \nfurther strengthen IBA Dosimetrys product \noffering. IBA subscribed to a convertible loan issued\nby PanTera for EUR 3.5 millions to further\nsupport the development of the production\nof Ac.225. === Page 177 ===\nIBA Annual Report 2023 \n174. 15.",
  "similarity_score": 0.05262764073181837,
  "metadata": {
    "filename": "annual_report_text (1).txt",
    "filepath": "input\\annual_report_text (1).txt",
    "chunk_id": 982,
    "start_char_idx": 0,
    "end_char_idx": 0,
    "page": null,
    "section": null
  }
}